Loss of effectiveness with an implanted drug delivery system for intrathecal pain therapy due to corrosion

被引:0
|
作者
Reining, Marco [1 ,3 ]
Kretzschmar, Michael [1 ,2 ]
机构
[1] Dept Pain Med & Palliat Care, SRH Wald Klinikum Gera GmbH, Gera, Germany
[2] SRH Univ Appl Hlth Sci, Gera, Germany
[3] SRH Wald Klinikum Gera GmbH, Dept Pain Med & Palliat Care, Str Friedens 122, D-07549 Gera, Germany
关键词
corrosion; implantable infusion pumps; intrathecal drug delivery system; opioid analgesics; CONFERENCE PACC RECOMMENDATIONS; MORPHINE THERAPY; COMPLICATIONS; CATHETER; MALFUNCTION;
D O I
10.1111/papr.13187
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
IntroductionIntrathecal drug delivery is an established invasive treatment option. Most common complication is catheter malfunction, which can lead to overdose or withdrawal. Case PresentationA 61-year-old female patient underwent an elective replacement of an intrathecal drug delivery pump. The patient complained about a loss of effectiveness over the past 2 years. Intraoperatively, a white mass corresponding to morphine precipitation in the pump pocket was found, which appeared to be due to corrosion at the pump-catheter connection site. ConclusionsRecommendations on how to deal with the decreasing effectiveness of intrathecal drug delivery and on intraoperative catheter handling are provided.
引用
收藏
页码:459 / 462
页数:4
相关论文
共 49 条
  • [41] Cancer patients quality of life after intrathecal drug delivery for advanced pain management: a patient-reported outcome analysis
    Goel, Vasudha
    Kaizer, Alexander
    Darrow, David
    Rosielle, Drew
    Owens, Benjamin
    Blaes, Anne
    PAIN MEDICINE, 2025, 26 (05) : 261 - 268
  • [42] Can Cerebrospinal Fluid Pressure Detect Catheter Complications in Patients Who Experience Loss of Effectiveness With Intrathecal Baclofen Therapy?
    Saulino, Michael
    Turner, Michael
    Miesel, Keith
    Cochran, Felicia R.
    Stromberg, Katherine
    Fehrmann, Elizabeth
    Markert, Mary
    Spencer, Robert
    NEUROMODULATION, 2017, 20 (02): : 187 - 197
  • [43] Patient Satisfaction Following Intrathecal Targeted Drug Delivery for Benign Chronic Pain: Results of a Single-Center Survey Study
    Schultz, David M.
    Orhurhu, Vwaire
    Khan, Faizan
    Hagedorn, Jonathan M.
    Abd-Elsayed, Alaa
    NEUROMODULATION, 2020, 23 (07): : 1009 - 1017
  • [44] EXTRADURAL BLOOD PATCH OF A CEREBROSPINAL-FLUID CUTANEOUS FISTULA IN THE PRESENCE OF AN INTRATHECAL DRUG-DELIVERY SYSTEM
    HARDY, PAJ
    ANESTHESIOLOGY, 1994, 81 (05) : 1299 - 1300
  • [45] Lumbar Subarachnoid Hematoma Following an Epidural Blood Patch for Meningeal Puncture Headache Related to the Implantation of an Intrathecal Drug Delivery System
    Hustak, Erik C.
    Engle, Mitchell P.
    Viswanathan, Ashwin
    Koyyalagunta, Dhanalakshmi
    PAIN PHYSICIAN, 2014, 17 (03) : E405 - E411
  • [46] BACTERIOLOGY, DRUG STABILITY AND EXCHANGE OF PERCUTANEOUS DELIVERY SYSTEMS AND ANTIBACTERIAL FILTERS IN LONG-TERM INTRATHECAL INFUSION OF OPIOID DRUGS AND BUPIVACAINE IN REFRACTORY PAIN
    NITESCU, P
    HULTMAN, E
    APPELGREN, L
    LINDER, LE
    CURELARU, I
    CLINICAL JOURNAL OF PAIN, 1992, 8 (04) : 324 - 337
  • [47] Preventing Post Dural Puncture Headache after Intrathecal Drug Delivery System Implantation Through Preventive Fibrin Glue Application: A Retrospective Study
    Dupoiron, Denis
    Narang, Sanjeet
    Seegers, Valerie
    Lebrec, Nathalie
    Bore, Francois
    Jaoul, Virginie
    Pechard, Marie
    Hamon, Sabrina Jubier
    Delorme, Thierry
    Douillard, Thomas
    PAIN PHYSICIAN, 2021, 24 (02) : E211 - E220
  • [48] The Effectiveness of a Bioactive Healing Abutment as a Local Drug Delivery System to Impact Peri-Implant Mucositis: A Prospective Case Series Study
    Wychowanski, Piotr
    Nowak, Maciej
    Miskiewicz, Andrzej
    Morawiec, Tadeusz
    Wolinski, Jaroslaw
    Kucharski, Zbigniew
    Passarelli, Pier Carmine
    Bodnarenko, Alina
    Lopez, Michele Antonio
    PHARMACEUTICS, 2023, 15 (01)
  • [49] Buprenorphine Transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: A multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study
    Landau, Craig J.
    Carr, William D.
    Razzetti, Albert J.
    Sessler, Nelson E.
    Munera, Catherine
    Ripa, Steven R.
    CLINICAL THERAPEUTICS, 2007, 29 (10) : 2179 - 2193